1![Intersect ENT Announces FDA Submission of NOVA Bioabsorbable Steroid Releasing Implant for Patients with Chronic Sinus Disease MENLO PARK, Calif.—Aug. 1, 2016—Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to Intersect ENT Announces FDA Submission of NOVA Bioabsorbable Steroid Releasing Implant for Patients with Chronic Sinus Disease MENLO PARK, Calif.—Aug. 1, 2016—Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to](https://www.pdfsearch.io/img/5a983f00bbfe583a44cfb1c91bed3478.jpg) | Add to Reading ListSource URL: propelopens.com- Date: 2016-07-29 19:00:51
|
---|
2![PROPEL® (mometasone furoate implant, 370 µg) Instructions For Use CAREFULLY READ ALL INSTRUCTIONS PRIOR TO USE STERILE: STORAGE: PROPEL® (mometasone furoate implant, 370 µg) Instructions For Use CAREFULLY READ ALL INSTRUCTIONS PRIOR TO USE STERILE: STORAGE:](https://www.pdfsearch.io/img/43835f4857577fd45f124ec358c07a67.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2016-04-01 12:43:40
|
---|
3![Intersect ENT Announces Publication of PROGRESS Study of Steroid Releasing Implant in Patients With Frontal Sinus Disease Results Demonstrate Clinical Benefits of PROPEL mini in Difficult-to-Treat Patient Population MENL Intersect ENT Announces Publication of PROGRESS Study of Steroid Releasing Implant in Patients With Frontal Sinus Disease Results Demonstrate Clinical Benefits of PROPEL mini in Difficult-to-Treat Patient Population MENL](https://www.pdfsearch.io/img/3fac6c1ef233c6120a5789b7070107d3.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2016-07-08 12:30:12
|
---|
4![164 Warburton Avenue • Hawthorne, NJ 07506 • ( • www.pallottarauzman.com Notes from the Doctors T o all my family, friends and patients, can you believe it’s been a year already since 164 Warburton Avenue • Hawthorne, NJ 07506 • ( • www.pallottarauzman.com Notes from the Doctors T o all my family, friends and patients, can you believe it’s been a year already since](https://www.pdfsearch.io/img/49124fe90d6b6125f81733c53109d630.jpg) | Add to Reading ListSource URL: www.pallottarauzman.comLanguage: English - Date: 2014-03-09 22:36:27
|
---|
5![Foto_Armando_Lopes_NYC.indd Foto_Armando_Lopes_NYC.indd](https://www.pdfsearch.io/img/ec8269699c6ad13964057170583cf38f.jpg) | Add to Reading ListSource URL: www.dental.upenn.eduLanguage: English - Date: 2015-11-16 17:45:14
|
---|
6![Intersect ENT Announces Completion of Enrollment in RESOLVE II Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis Company Also Announces Publication of Positive Six-Month Results from RESOLVE Clinica Intersect ENT Announces Completion of Enrollment in RESOLVE II Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis Company Also Announces Publication of Positive Six-Month Results from RESOLVE Clinica](https://www.pdfsearch.io/img/7040f7369c55cff4cb155ccfbcfdba74.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2016-06-01 10:43:20
|
---|
7![Intersect ENT Recognized for Gender Diversity by Watermark and UC Davis Company Also Recognized in Deloitte’s 2015 Technology Fast 500 MENLO PARK, Calif., November 17, 2015 – Intersect ENT, Inc. (Nasdaq:XENT), a comp Intersect ENT Recognized for Gender Diversity by Watermark and UC Davis Company Also Recognized in Deloitte’s 2015 Technology Fast 500 MENLO PARK, Calif., November 17, 2015 – Intersect ENT, Inc. (Nasdaq:XENT), a comp](https://www.pdfsearch.io/img/47e02d91e9c60353ada1d287d912e88d.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2015-11-17 11:28:47
|
---|
8![Intersect ENT Announces Data Further Demonstrating Health Economic Value of PROPEL Steroid Releasing Implants Savings Associated with Reduced Post-Operative Interventions Support Use of PROPEL MENLO PARK, Calif., Novembe Intersect ENT Announces Data Further Demonstrating Health Economic Value of PROPEL Steroid Releasing Implants Savings Associated with Reduced Post-Operative Interventions Support Use of PROPEL MENLO PARK, Calif., Novembe](https://www.pdfsearch.io/img/f7d29d867333bfd5582a4d7556f4341b.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2015-11-10 10:16:52
|
---|
9![Intersect ENT Announces Publication of Position Statement from AAO-HNS on Use of Biomaterials Statement Supports Use of PROPEL, the Only FDA-Approved Biomaterial Used to Improve Patient Outcomes in Sinus Procedures Menlo Intersect ENT Announces Publication of Position Statement from AAO-HNS on Use of Biomaterials Statement Supports Use of PROPEL, the Only FDA-Approved Biomaterial Used to Improve Patient Outcomes in Sinus Procedures Menlo](https://www.pdfsearch.io/img/fb3b30dc786710191e5b72b24f30ebe1.jpg) | Add to Reading ListSource URL: propelopens.comLanguage: English - Date: 2015-10-21 16:28:17
|
---|
10![](https://www.pdfsearch.io/img/e078f0ba76f3b41e22f5330d1d91fef7.jpg) | Add to Reading ListSource URL: www.top-messe-service.comLanguage: English - Date: 2011-02-24 12:19:27
|
---|